ZA835674B - 4h-1,4-benzothiazines,and processes for their preparation - Google Patents

4h-1,4-benzothiazines,and processes for their preparation

Info

Publication number
ZA835674B
ZA835674B ZA835674A ZA835674A ZA835674B ZA 835674 B ZA835674 B ZA 835674B ZA 835674 A ZA835674 A ZA 835674A ZA 835674 A ZA835674 A ZA 835674A ZA 835674 B ZA835674 B ZA 835674B
Authority
ZA
South Africa
Prior art keywords
halogen
aryl
hydroxyl
alkyl
mono
Prior art date
Application number
ZA835674A
Other languages
English (en)
Inventor
Ekkehard Niemers
Rudi Gruetmann
Mardin Mithat
Wolf-Dieter Busse
Horst Meyer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA835674B publication Critical patent/ZA835674B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Dental Preparations (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Eyeglasses (AREA)
  • Ink Jet (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
ZA835674A 1982-08-04 1983-08-03 4h-1,4-benzothiazines,and processes for their preparation ZA835674B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823229121 DE3229121A1 (de) 1982-08-04 1982-08-04 4h-1,4-benzothiazine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
ZA835674B true ZA835674B (en) 1984-04-25

Family

ID=6170116

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA835674A ZA835674B (en) 1982-08-04 1983-08-03 4h-1,4-benzothiazines,and processes for their preparation

Country Status (14)

Country Link
EP (1) EP0100527B1 (xx)
JP (1) JPS5944368A (xx)
KR (1) KR840005727A (xx)
AT (1) ATE24724T1 (xx)
AU (1) AU1758683A (xx)
DE (2) DE3229121A1 (xx)
DK (1) DK354483A (xx)
ES (1) ES524708A0 (xx)
FI (1) FI832782A (xx)
GR (1) GR79356B (xx)
IL (1) IL69389A0 (xx)
NO (1) NO832664L (xx)
PT (1) PT77096B (xx)
ZA (1) ZA835674B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3426564A1 (de) * 1984-07-19 1986-01-30 Bayer Ag, 5090 Leverkusen Verwendung von 4h-1,4-benzothiazinen bei der prophylaxe und therapie von erkrankungen der atemwege, entzuendungen/rheuma, thromboembolischen erkrankungen, ischaemien und infarkten, herzrhythmusstoerungen, arteriosklerose und dermatosen, arzneimittel zu diesem zweck sowie wirkstoffe, die in diesen arzneimitteln enthalten sind
DE3540702A1 (de) * 1985-11-16 1987-05-21 Bayer Ag 1h-pyrido-(2,3-b) (1,4)-thiazine
DE3545097A1 (de) * 1985-12-19 1987-07-02 Bayer Ag 1-h-pyrido-(3,2-b)(1,4)-thiazine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4397849A (en) * 1980-12-30 1983-08-09 Fujisawa Pharmaceutical Co., Ltd. Benzothiazine derivatives
DE3111487A1 (de) * 1981-03-24 1982-12-30 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2,3-dihydro-4h-1,4 dihydro-1,4-benzothiazinen

Also Published As

Publication number Publication date
EP0100527A1 (de) 1984-02-15
DE3368925D1 (en) 1987-02-12
PT77096A (en) 1983-08-01
AU1758683A (en) 1984-02-09
DK354483A (da) 1984-02-05
KR840005727A (ko) 1984-11-16
ATE24724T1 (de) 1987-01-15
DK354483D0 (da) 1983-08-03
ES8404682A1 (es) 1984-05-01
PT77096B (en) 1986-03-12
FI832782A (fi) 1984-02-05
NO832664L (no) 1984-02-06
EP0100527B1 (de) 1987-01-07
DE3229121A1 (de) 1984-02-09
JPS5944368A (ja) 1984-03-12
IL69389A0 (en) 1983-11-30
FI832782A0 (fi) 1983-08-02
GR79356B (xx) 1984-10-22
ES524708A0 (es) 1984-05-01

Similar Documents

Publication Publication Date Title
ZA881077B (en) Macromolecular platinum antitumor compounds
PT77082A (en) Process for preparing 2-substituted 4-amino-6,7-dimethoxyquinolines
YU78980A (en) Machinery for treating wet sbstances, particularly pulp-type materials, by means of heating or cooling
FR2311776A1 (fr) Diamino-2,4 bromo-5 chloro-6 pyrimidines et procede pour leur preparation
IT8022331A0 (it) Essiccazione o rispettivamente per procedimento per il trattamento la calcinazione. termico, in particolare per la
ES2121993T3 (es) Derivados de 4-oxo-2-tioxoimidazolidina como sustancias inhibidoras de la agregacion de plaquetas sanguineas.
EP0200024A3 (en) 3-cyano-pyridines, process for their preparation and their pharmaceutical use
ZA835674B (en) 4h-1,4-benzothiazines,and processes for their preparation
NO156615C (no) Fremgangsmaate ved regulering av lommeslipeapparater.
KE3721A (en) N-((4-(3-substituted pyridyl)piperazino)alkyl)azaspirodecanediones
DE3167712D1 (en) Process for the preparation of chloropyridines substituted with methyl or trifluoromethyl groups
PT84819A (en) Process for preparing 2-pyridil-penem compounds
DE3876381D1 (de) Verwendung von 2-pyrimidinyl-1-piperazin-derivaten.
GR77704B (xx)
YU82676A (en) Furnace for thermally treating solid lump fuel
FR2520742B1 (fr) 1,3,4-thiadiazolo(3,2-a)pyrimidines substituees utiles comme medicaments et procede de leur preparation
FR2518543B1 (fr) Procede de preparation de 3-oxydes de 6-(3,6-dihydro-1(2h)-pyridyl)-pyrimidines
PT76459B (en) Process for preparing substituted 3,4-diamino-1,2,process for the preparation of 3,4-diamino-1,2,5-tiadiazoles substituted with anti-histaminic activi5-thiadiazoles having histamine h2-receptor antagoty nist activity
PT69764A (en) New improved process for the preparation of 2-isopropylamino pyrimidine
ES8707187A1 (es) Procedimiento mejorado para la preparacion de 1(4-fluorofenil) sulfonil -4-4-7(trifluorometil-4-quinolinil)amino(benzoil) piperazina
FR2492826B1 (fr) Acides et sels mineraux d'acides mono- et bis-(dialcoxy-1,3-propyl-2) phosphoriques et leur procede d'obtention
JPS5232895A (en) Process for controlling supplying quantity of lime in the wet recovery process of sulfur in the waste gas as gypsum with lime
BE893833A (fr) Procede de preparation de 3-oxydes de 6- (3,6-dihydro-1 (2h) - pyridyl) -pyrimidines
GB2070600B (en) Lminium salts and process for preparing 5-(cyano or carbomyl)-(3,4-bipyridin)-6(1h)-one
YU211180A (en) Process for preparing 2-(2-chloro-4-cyclopropyl-phenylimino)-imidazolidine